As you know, hepatocellular carcinoma is a challenge. Too often patients are diagnosed at an advanced stage; often patients are not referred based on a nihilistic attitude which should belong to the past. Several therapeutic options are available and to select the best for each patient requires expertise.
For the benefit of our patients we plan to organize a HCC Update starting at 13:30 on the 19th September 2017 in Zurich focusing on hepatocellular carcinoma and bringing together the different specialties.
This event will have CME recognition.
Prof. Pierre Nahon, Hôpital Jean Verdier Bondy, Paris
HCC surveillance after Hepatitis C
Prof. Christian Toso, HUG Genève
Listing for transplantation patients with HCC
Prof. Philip Johnson, University of Liverpool
Pre-radiology HCC
Pause
Presentation of the prize winner
Dr. Anja Lachenmayer, Inselspital
Microwave ablation for HCC
Prof. Chris Verslype, KU Leuven
New systemic therapies (incl. Comparison with SIRT)
Prof. J.-F. Dufour, Head of Hepatology Department, University Hospital of Berne
Closing remarks
Apéro
